DK173178B1 - Insulinderivater samt disse forbindelsers fysiologisk tålelige salte, fremgangsmåde til fremstilling deraf, anvendelse af d - Google Patents

Insulinderivater samt disse forbindelsers fysiologisk tålelige salte, fremgangsmåde til fremstilling deraf, anvendelse af d Download PDF

Info

Publication number
DK173178B1
DK173178B1 DK198906698A DK669889A DK173178B1 DK 173178 B1 DK173178 B1 DK 173178B1 DK 198906698 A DK198906698 A DK 198906698A DK 669889 A DK669889 A DK 669889A DK 173178 B1 DK173178 B1 DK 173178B1
Authority
DK
Denmark
Prior art keywords
insulin
arg
formula
chain
derivatives
Prior art date
Application number
DK198906698A
Other languages
Danish (da)
English (en)
Other versions
DK669889A (da
DK669889D0 (da
Inventor
Karl Geisen
Laszlo Vertesy
Klaus Sauber
Guenther Johannes Riess
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK669889D0 publication Critical patent/DK669889D0/da
Publication of DK669889A publication Critical patent/DK669889A/da
Application granted granted Critical
Publication of DK173178B1 publication Critical patent/DK173178B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK198906698A 1988-12-29 1989-12-28 Insulinderivater samt disse forbindelsers fysiologisk tålelige salte, fremgangsmåde til fremstilling deraf, anvendelse af d DK173178B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3844211A DE3844211A1 (de) 1988-12-29 1988-12-29 Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DE3844211 1988-12-29

Publications (3)

Publication Number Publication Date
DK669889D0 DK669889D0 (da) 1989-12-28
DK669889A DK669889A (da) 1990-06-30
DK173178B1 true DK173178B1 (da) 2000-03-06

Family

ID=6370457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906698A DK173178B1 (da) 1988-12-29 1989-12-28 Insulinderivater samt disse forbindelsers fysiologisk tålelige salte, fremgangsmåde til fremstilling deraf, anvendelse af d

Country Status (20)

Country Link
US (1) US5506202A (no)
EP (1) EP0376156B1 (no)
JP (1) JP3129722B2 (no)
KR (1) KR900009698A (no)
AT (1) ATE136038T1 (no)
AU (1) AU623963B2 (no)
CA (1) CA2006818C (no)
DE (2) DE3844211A1 (no)
DK (1) DK173178B1 (no)
ES (1) ES2085271T3 (no)
FI (1) FI102843B1 (no)
GR (1) GR3019560T3 (no)
HU (1) HU205172B (no)
IE (1) IE73672B1 (no)
IL (1) IL92905A (no)
NO (1) NO180379C (no)
NZ (1) NZ231944A (no)
PH (1) PH27425A (no)
PT (1) PT92757B (no)
ZA (1) ZA899946B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
TW224471B (no) * 1991-11-26 1994-06-01 Lilly Co Eli
JP3872105B2 (ja) * 1995-03-17 2007-01-24 ノボ ノルディスク アクティーゼルスカブ インスリン誘導体
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
US6746853B1 (en) 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
US6323311B1 (en) 1999-09-22 2001-11-27 University Of Utah Research Foundation Synthesis of insulin derivatives
AU2002346490A1 (en) * 2001-12-20 2003-07-09 Eli Lilly And Company Insulin molecule having protracted time action
BRPI0409600A (pt) * 2003-04-29 2006-04-18 Lilly Co Eli análogo de insulina, composição, método de tratamento de hiperglicemia, e, análogo de pró-insulina
US7704955B2 (en) * 2004-11-24 2010-04-27 Neopro Pain, Inc. Methods and compositions for modulating conditions in both mammals and plants
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
PL373543A1 (pl) * 2005-03-10 2006-09-18 Instytut Biotechnologii i Antybiotyków Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
US20060212009A1 (en) * 2005-03-16 2006-09-21 Accisano Nicholas G Iii Drainage catheter hub with rotatable lever handle
US7824367B2 (en) * 2005-08-17 2010-11-02 Merit Medical Systems, Inc. Drainage catheter with locking hub
WO2007081824A2 (en) * 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
US7557088B2 (en) * 2006-03-28 2009-07-07 Neopro Labs, Llc Methods and compositions for treating conditions
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
EP2049149B1 (en) * 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
US9233226B2 (en) * 2006-08-22 2016-01-12 Merit Medical Systems, Inc. Drainage catheter with pig-tail straightener
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
WO2008043033A2 (en) * 2006-10-04 2008-04-10 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
CA2683288A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
EP2164458A1 (en) * 2007-06-01 2010-03-24 Novo Nordisk A/S Stable non-aqueous pharmaceutical compositions
WO2009012472A2 (en) * 2007-07-18 2009-01-22 Neopro Labs, Llc Methods and compositions for treating conditions
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US8993516B2 (en) * 2008-04-14 2015-03-31 Case Western Reserve University Meal-time insulin analogues of enhanced stability
KR20110021758A (ko) * 2008-04-22 2011-03-04 케이스 웨스턴 리저브 유니버시티 이형체-특이적 인슐린 유사체
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
MY189079A (en) 2009-12-11 2022-01-25 Univ Case Western Reserve Insulin analogues with chlorinated amino acids
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
CA2961037A1 (en) 2014-10-06 2016-04-14 Case Western Reserve University Biphasic single-chain insulin analogues
GB2549275B (en) * 2016-04-11 2018-05-09 Tectonic Facades Ltd Construction assembly
HRP20221324T1 (hr) 2016-12-16 2022-12-23 Novo Nordisk A/S Farmaceutski pripravci koji sadrže inzulin
WO2024137820A1 (en) * 2022-12-20 2024-06-27 The Board Of Trustees Of The Leland Stanford Junior University Insulin receptor antagonist

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
US4343898A (en) * 1980-02-11 1982-08-10 Novo Industri A/S Process for preparing esters of human insulin
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
DE3636903A1 (de) * 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
DE3545595A1 (de) * 1985-12-21 1987-06-25 Behringwerke Ag Dispersionspolymere, verfahren zu ihrer herstellung und ihre verwendung
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3805150A1 (de) * 1987-04-11 1988-10-20 Hoechst Ag Gentechnologisches verfahren zur herstellung von polypeptiden
DE3714866A1 (de) * 1987-05-05 1988-11-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser

Also Published As

Publication number Publication date
HU205172B (en) 1992-03-30
AU623963B2 (en) 1992-05-28
CA2006818C (en) 2000-05-23
PH27425A (en) 1993-06-21
JPH02225498A (ja) 1990-09-07
ZA899946B (en) 1990-09-26
FI102843B (fi) 1999-02-26
DK669889A (da) 1990-06-30
GR3019560T3 (en) 1996-07-31
DE3844211A1 (de) 1990-07-05
NZ231944A (en) 1993-02-25
PT92757B (pt) 1995-12-29
FI896279A0 (fi) 1989-12-27
NO180379C (no) 1997-04-09
AU4733289A (en) 1990-07-05
IL92905A0 (en) 1990-09-17
EP0376156A3 (de) 1991-05-02
CA2006818A1 (en) 1990-06-29
EP0376156B1 (de) 1996-03-27
KR900009698A (ko) 1990-07-05
ATE136038T1 (de) 1996-04-15
EP0376156A2 (de) 1990-07-04
IE894200L (en) 1990-06-29
HUT53150A (en) 1990-09-28
JP3129722B2 (ja) 2001-01-31
ES2085271T3 (es) 1996-06-01
IL92905A (en) 1994-10-21
FI102843B1 (fi) 1999-02-26
DE58909633D1 (de) 1996-05-02
US5506202A (en) 1996-04-09
NO895296L (no) 1990-07-02
NO180379B (no) 1996-12-30
IE73672B1 (en) 1997-07-02
DK669889D0 (da) 1989-12-28
PT92757A (pt) 1990-06-29
NO895296D0 (no) 1989-12-28
HU896781D0 (en) 1990-03-28

Similar Documents

Publication Publication Date Title
DK173178B1 (da) Insulinderivater samt disse forbindelsers fysiologisk tålelige salte, fremgangsmåde til fremstilling deraf, anvendelse af d
EP0419504B1 (en) Insulin analogues
AU630912B2 (en) Insulin analogs
US5164366A (en) Human insulin analogues
US5700662A (en) Process for preparing insulin analogs
KR940000756B1 (ko) 인슈린 유사체의 제조방법
US5716927A (en) Insulin analogs having a modified B-chain
AU2004295023A1 (en) Single-chain insulin
CA1246478A (en) Process for the preparation of insulin derivatives, the b chain of which is lengthened c-terminally, novel insulin derivatives modified by bases, agents containing these derivatives and their use
US20060264606A1 (en) Processes for making acylated insulin
WO1992000321A1 (en) Novel, protracted insulin analogues
CZ290079B6 (cs) Způsob produkce inzulinu a meziprodukt pro tento způsob
EP0511003B1 (en) Superactive GRF analogs
NO830241L (no) Antigenisk lineaere peptidforbindelser.
DK166730B (da) Humaninsulinanaloger og deres farmaceutisk tolerable salte samt farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
PUP Patent expired